Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 20Gastrointestinal 12Gynecologic 6Tumor-Agnostic 4Thoracic 3Sarcoma 3CNS 3Head & Neck 2Genitourinary 2Dermatologic 1

Conditions

Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Mouth Neoplasms 1Melanoma 1Lung Neoplasms 1Liver Neoplasms 1Head and Neck Neoplasms 1HER2-mutant Non-Small Cell Lung Cancer 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Anus Neoplasms 1Adenocarcinoma 1

Interventions

Carboplatin 111pembrolizumab 93Pemetrexed 85Cisplatin 69Specimen Handling 41durvalumab 37Paclitaxel 36Nivolumab 34Docetaxel 34atezolizumab 33osimertinib 31Magnetic Resonance Spectroscopy 30Gemcitabine 22Radiotherapy 21Etoposide 21130-nm albumin-bound paclitaxel 19Cetuximab 17amivantamab 15Radiosurgery 13Platinum 13Bevacizumab 13Radiation 12lazertinib 11cemiplimab 11Taxes 11Ipilimumab 11Immunoglobulin G 11Topotecan 10Drug Therapy 10Disulfides 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
trastuzumab deruxtecan × Thoracic × 30 days × Clear all
NCT07124000 2026-06-01

DP-04

AstraZeneca

Recruiting
100 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Adenocarcinoma, Anus Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Melanoma, Mouth Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Testicular Neoplasms, Thyroid Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gastrointestinal Stromal Tumors, Small Cell Lung Carcinoma

NCT07012031 2026-05-13

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

National Cancer Institute (NCI)

Phase 1/2 Recruiting
37 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05246514 2026-05-12

DL-05

AstraZeneca

Phase 2 Active not recruiting
72 enrolled 19 charts
Thoracic

HER2-mutant Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡